Eur Respir J 2002; 20:799-805
Copyright ©ERS Journals Ltd 2002
Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey
S. Rennard1,
M. Decramer2,
P.M.A. Calverley3,
N.B. Pride4,
J.B. Soriano5,
P.A. Vermeire6 and
J. Vestbo7
1 University of Nebraska, Pulmonary and Critical Care Medicine Section, Omaha, NE, USA. 2 Respiratory Division, Catholic University of Leuven, Leuven, Belgium. 3 University of Liverpool, Dept of Medicine, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK. 4 Thoracic Medicine, National Heart and Lung Institute, Imperial College School of Medicine, London, UK. 5 Worldwide Epidemiology, GlaxoSmithKline Research and Development, Greenford, UK. 6 Dept of Respiratory Medicine, University of Antwerp, Antwerp, Belgium. 7 Dept of Respiratory Medicine, Hvidovre University Hospital, Copenhagen, Denmark
CORRESPONDENCE: S. Rennard, Pulmonary and Critical Care Medicine Section, University of Nebraska Medical Center, 985125 Nebraska Medical Center, Omaha, NE 68198-5125, USA. Fax: 1 402 5594878. E-mail: srennard@unmc.edu
Keywords: chronic obstructive pulmonary disease, epidemiology, guidelines, management, subject perspective
Received: December 10, 2001
Accepted May 1, 2002
This study was supported by GlaxoSmithKline Research and Development, Greenford, UK.
To date, no international surveys estimating the burden of chronic obstructive pulmonary disease (COPD) in the general population have been published. The Confronting COPD International Survey aimed to quantify morbidity and burden in COPD subjects in 2000.
From a total of 201,921 households screened by random-digit dialling in the USA, Canada, France, Italy, Germany, the Netherlands, Spain and the UK, 3,265 subjects with a diagnosis of COPD, chronic bronchitis or emphysema, or with symptoms of chronic bronchitis, were identified.
The mean age of the subjects was 63.3 yrs and 44.2% were female. Subjects with COPD in North America and Europe appear to underestimate their morbidity, as shown by the high proportion of subjects with limitations to their basic daily life activities, frequent work loss (45.3% of COPD subjects of <65 yrs reported work loss in the past year) and frequent use of health services (13.8% of subjects required emergency care in the last year), and may be undertreated. There was a significant disparity between subjects' perception of disease severity and the degree of severity indicated by an objective breathlessness scale. Of those with the most severe breathlessness (too breathless to leave the house), 35.8% described their condition as mild or moderate, as did 60.3% of those with the next most severe degree of breathlessness (breathless after walking a few minutes on level ground).
This international survey confirmed the great burden to society and high individual morbidity associated with chronic obstructive pulmonary disease in subjects in North America and Europe.
This article has been cited by other articles:

|
 |

|
 |
 
S Dorman, C Jolley, A Abernethy, D Currow, M Johnson, M Farquhar, G Griffiths, T Peel, S Moosavi, A Byrne, et al.
Researching breathlessness in palliative care: consensus statement of the National Cancer Research Institute Palliative Care Breathlessness Subgroup
Palliative Medicine,
April 1, 2009;
23(3):
213 - 227.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
S. I. Rennard and J. Vestbo
Natural Histories of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
December 15, 2008;
5(9):
878 - 883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Rodriguez-Roisin and J. B. Soriano
Chronic Obstructive Pulmonary Disease with Lung Cancer and/or Cardiovascular Disease
Proceedings of the ATS,
December 1, 2008;
5(8):
842 - 847.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Roche, F. Dalmay, T. Perez, C. Kuntz, A. Vergnenegre, F. Neukirch, J-P. Giordanella, and G. Huchon
Impact of chronic airflow obstruction in a working population
Eur. Respir. J.,
June 1, 2008;
31(6):
1227 - 1233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Albers, T Schermer, Y Heijdra, J Molema, R Akkermans, and C van Weel
Predictive value of lung function below the normal range and respiratory symptoms for progression of chronic obstructive pulmonary disease
Thorax,
March 1, 2008;
63(3):
201 - 207.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi
Definition, epidemiology and natural history of COPD
Eur. Respir. J.,
November 1, 2007;
30(5):
993 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. Mannino and S. Braman
The Epidemiology and Economics of Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
October 1, 2007;
4(7):
502 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. J. Martinez, J. L. Curtis, F. Sciurba, J. Mumford, N. D. Giardino, G. Weinmann, E. Kazerooni, S. Murray, G. J. Criner, D. D. Sin, et al.
Sex Differences in Severe Pulmonary Emphysema
Am. J. Respir. Crit. Care Med.,
August 1, 2007;
176(3):
243 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A Cleland, A. J Lee, and S. Hall
Associations of depression and anxiety with gender, age, health-related quality of life and symptoms in primary care COPD patients
Fam. Pract.,
June 1, 2007;
24(3):
217 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. O'Donnell, R. B. Banzett, V. Carrieri-Kohlman, R. Casaburi, P. W. Davenport, S. C. Gandevia, A. F. Gelb, D. A. Mahler, and K. A. Webb
Pathophysiology of Dyspnea in Chronic Obstructive Pulmonary Disease: A Roundtable
Proceedings of the ATS,
May 1, 2007;
4(2):
145 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Madani, V. De Maertelaer, J. Zanen, and P. A. Gevenois
Pulmonary Emphysema: Radiation Dose and Section Thickness at Multidetector CT Quantification--Comparison with Macroscopic and Microscopic Morphometry
Radiology,
April 1, 2007;
243(1):
250 - 257.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-C. Wang, J.-M. Lin, C.-Y. Li, L.-T. Lee, Y.-L. Guo, and F.-C. Sung
Prevalence and Risks of Chronic Airway Obstruction: A Population Cohort Study in Taiwan
Chest,
March 1, 2007;
131(3):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. A. Calverley
Exercise and dyspnoea in COPD
Eur. Respir. Rev.,
December 1, 2006;
15(100):
72 - 79.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. E. O'Donnell, F. Sciurba, B. Celli, D. A. Mahler, K. A. Webb, C. J. Kalberg, and K. Knobil
Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD.
Chest,
September 1, 2006;
130(3):
647 - 656.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Stenfors
Physician-Diagnosed COPD Global Initiative for Chronic Obstructive Lung Disease Stage IV in Ostersund, Sweden: Patient Characteristics and Estimated Prevalence.
Chest,
September 1, 2006;
130(3):
666 - 671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. M. G. Halpin and M. Miravitlles
Chronic Obstructive Pulmonary Disease: The Disease and Its Burden to Society
Proceedings of the ATS,
September 1, 2006;
3(7):
619 - 623.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Smith, E. Owen, J. Earis, and A. Woodcock
Cough in COPD: Correlation of Objective Monitoring With Cough Challenge and Subjective Assessments.
Chest,
August 1, 2006;
130(2):
379 - 385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Kessler, E. Stahl, C. Vogelmeier, J. Haughney, E. Trudeau, C.-G. Lofdahl, and M. R. Partridge
Patient Understanding, Detection, and Experience of COPD Exacerbations: An Observational, Interview-Based Study.
Chest,
July 1, 2006;
130(1):
133 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Mahler
Mechanisms and Measurement of Dyspnea in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2006;
3(3):
234 - 238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. A. Calverley
Dynamic Hyperinflation: Is It Worth Measuring?
Proceedings of the ATS,
May 1, 2006;
3(3):
239 - 244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G C Donaldson and J A Wedzicha
COPD exacerbations {middle dot} 1: Epidemiology
Thorax,
February 1, 2006;
61(2):
164 - 168.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. R. Chapman, D. M. Mannino, J. B. Soriano, P. A. Vermeire, A. S. Buist, M. J. Thun, C. Connell, A. Jemal, T. A. Lee, M. Miravitlles, et al.
Epidemiology and costs of chronic obstructive pulmonary disease
Eur. Respir. J.,
January 1, 2006;
27(1):
188 - 207.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli
Chronic Obstructive Pulmonary Disease: From Unjustified Nihilism to Evidence-based Optimism.
Proceedings of the ATS,
January 1, 2006;
3(1):
58 - 65.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Casaburi and J. Porszasz
Reduction of hyperinflation by pharmacologic and other interventions.
Proceedings of the ATS,
January 1, 2006;
3(2):
185 - 189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Stevenson, P. P. Walker, R. W. Costello, and P. M. A. Calverley
Lung Mechanics and Dyspnea during Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
December 15, 2005;
172(12):
1510 - 1516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Haughney, M. R. Partridge, C. Vogelmeier, T. Larsson, R. Kessler, E. Stahl, R. Brice, and C-G. Lofdahl
Exacerbations of COPD: quantifying the patient's perspective using discrete choice modelling
Eur. Respir. J.,
October 1, 2005;
26(4):
623 - 629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Decramer, R Gosselink, M Rutten-Van Molken, J Buffels, O Van Schayck, P-A Gevenois, R Pellegrino, E Derom, and W De Backer
Assessment of progression of COPD: report of a workshop held in Leuven, 11-12 March 2004
Thorax,
April 1, 2005;
60(4):
335 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Decramer, R Gosselink, P Bartsch, C-G Lofdahl, W Vincken, R Dekhuijzen, J Vestbo, R Pauwels, R Naeije, and T Troosters
Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004
Thorax,
April 1, 2005;
60(4):
343 - 349.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D A Seamark, S D Blake, C J Seamark, and D M. Halpin
Living with severe chronic obstructive pulmonary disease (COPD): perceptions of patients and their carers: An interpretative phenomenological analysis
Palliative Medicine,
October 1, 2004;
18(7):
619 - 625.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Viegi, G. Matteelli, A. Angino, A. Scognamiglio, S. Baldacci, J. B. Soriano, and L. Carrozzi
The Proportional Venn Diagram of Obstructive Lung Disease in the Italian General Population
Chest,
October 1, 2004;
126(4):
1093 - 1101.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Mahler, S. Huang, M. Tabrizi, and G. M. Bell
Efficacy and Safety of a Monoclonal Antibody Recognizing Interleukin-8 in COPD: A Pilot Study
Chest,
September 1, 2004;
126(3):
926 - 934.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. M. A. Wilkinson, G. C. Donaldson, J. R. Hurst, T. A. R. Seemungal, and J. A. Wedzicha
Early Therapy Improves Outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
June 15, 2004;
169(12):
1298 - 1303.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Buffels, J. Degryse, J. Heyrman, and M. Decramer
Office Spirometry Significantly Improves Early Detection of COPD in General Practice: The DIDASCO Study
Chest,
April 1, 2004;
125(4):
1394 - 1399.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Tzanakis, U. Anagnostopoulou, V. Filaditaki, P. Christaki, and N. Siafakas
Prevalence of COPD in Greece
Chest,
March 1, 2004;
125(3):
892 - 900.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Vestbo
COPD in the ECRHS
Thorax,
February 1, 2004;
59(2):
89 - 90.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Celli
A 62-Year-Old Woman With Chronic Obstructive Pulmonary Disease
JAMA,
November 26, 2003;
290(20):
2721 - 2729.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Decramer
Treatment of chronic respiratory failure: lung volume reduction surgery versus rehabilitation
Eur. Respir. J.,
November 16, 2003;
22(47_suppl):
47s - 56s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.L. Hansell, J.A. Walk, and J.B. Soriano
What do chronic obstructive pulmonary disease patients die from? Amultiple cause coding analysis
Eur. Respir. J.,
November 1, 2003;
22(5):
809 - 814.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
The pharmacoepidemiology of COPD: Recent advances and methodological discussion
Eur. Respir. J.,
September 1, 2003;
22(43_suppl):
1s - 44s.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Soriano, K. J. Davis, B. Coleman, G. Visick, D. Mannino, and N. B. Pride
The Proportional Venn Diagram of Obstructive Lung Disease: Two Approximations From the United States and the United Kingdom
Chest,
August 1, 2003;
124(2):
474 - 481.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.T. Weiss, D.L. DeMeo, and D.S. Postma
COPD: problems in diagnosis and measurement
Eur. Respir. J.,
June 1, 2003;
21(41_suppl):
4S - 12s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.K. Connolly
Chronic obstructive pulmonary disease: underdiagnosed, underinvestigated, inappropriately managed?
Eur. Respir. J.,
March 1, 2003;
21(3):
556 - 557.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.N.R. Dekhuijzen
The Confronting COPD International Survey: patients hardly know they have COPD
Eur. Respir. J.,
October 1, 2002;
20(4):
793 - 794.
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the European Respiratory Society.
|